Is Medicare Turning Seniors Into CBD Test Subjects? – Newswire
Medicare CBD use seniors is a growing concern due to unregulated products and lack of clinical oversight. Older adults self-treat with CBD for pain, anxiety, and sleep without standardized dosing. This raises safety and drug interaction risks that…
Is Medicare Turning Seniors Into CBD Test Subjects? – Morningstar
Medicare cannabinoid coverage is evolving, affecting seniors' access to CBD therapies. This shift raises concerns about unregulated products and drug interactions. Clinicians must guide older adults through these complexities carefully.
Study Finds No Link Between Smoking Cannabis and Cognitive Decline
Recent research on cannabis use and cognitive decline found no significant association in aging populations. This challenges previous assumptions about cannabis's neurotoxic effects. Clinicians can use this evidence to counsel patients more accurately…
Does Cannabis Use by Older Adults Accelerate Mental Decline? | Trending – Labroots
This article reviews cannabis use older adults mental decline and recent findings on cognitive safety. Evidence suggests no direct link between cannabis and accelerated mental decline in older adults. Clinicians should still assess individual risks and…
Navigating Delta-8 THC Regulatory Changes and Patient Access Concerns
Delta-8 THC regulatory changes are tightening access to hemp-derived products. Patients relying on delta-8 THC for symptom management face uncertainty as regulations evolve. Clinicians must understand these changes to guide patient care effectively.
CBD and CBG: Promising Treatments for Fatty Liver Disease
A new CBD and CBG fatty liver disease study highlights promising therapeutic potential for metabolic liver conditions. These cannabinoids may reduce liver fat and improve metabolic health. This study offers hope for new treatment options beyond lifestyle…
Should Medicare Reimburse Cannabis Products Without FDA Approval? | Newswire
Medicare cannabis reimbursement policy remains uncertain due to the lack of FDA approval for many cannabis products. This affects clinicians' ability to guide patients on coverage and treatment options. Understanding this policy gap is crucial for…
Exploring Cannabis Neuroprotective Benefits in Older Adults
Recent research highlights cannabis neuroprotective benefits older adults might experience, challenging traditional views on cognitive aging. These findings suggest potential brain health support from cannabis in elderly populations. Clinicians should…
The Cannabis Mental Health Evidence Gap: Association vs. Causation
The cannabis mental health evidence gap highlights the challenges in distinguishing association from causation in cognitive decline studies. Current research shows no clear link between cannabis use and dementia risk in older adults. Clinicians must…
Research on Cannabis Compounds and Metabolic Dysfunction in Adults
This article explores cannabis compounds metabolic dysfunction and their potential impact on reversing disease affecting one-third of adults. The research highlights emerging findings on cannabis compounds as a possible intervention for metabolic health.…